Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors

被引:48
作者
Spagnuolo, Lauren A. [1 ]
Eltschkner, Sandra [2 ]
Yu, Weixuan [1 ]
Daryaee, Fereidoon [1 ]
Davoodi, Shabnam [1 ]
Knudson, Susan E. [3 ]
Allen, Eleanor K. H. [1 ]
Merino, Jonathan [1 ]
Pschibul, Annica [2 ]
Moree, Ben [4 ]
Thivalapill, Neil [5 ]
Truglio, James J. [5 ]
Salafsky, Joshua [4 ]
Slayden, Richard A. [3 ]
Kisker, Caroline [2 ]
Tonge, Peter J. [1 ]
机构
[1] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA
[2] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany
[3] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
[4] Biodesy Inc, 384 Oyster Point Blvd, San Francisco, CA 94080 USA
[5] Great Neck South High Sch, 341 Lakeville Rd, Great Neck, NY 11020 USA
基金
美国国家卫生研究院;
关键词
CARRIER PROTEIN REDUCTASE; ENOYL-ACP REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS INHA; TIGHT-BINDING INHIBITOR; DRUG-RESISTANT STRAINS; SLOW-ONSET INHIBITION; 2ND-HARMONIC GENERATION; LEAD OPTIMIZATION; CRYSTAL-STRUCTURE; TRICLOSAN;
D O I
10.1021/jacs.6b11148
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A critical goal of lead compound selection and optimization is to maximize target engagement while minimizing off-target binding. Since target engagement is a function of both the thermodynamics and kinetics of drug target interactions, it follows that the structures of both the ground states and transition states on the binding reaction coordinate are needed to rationally modulate the lifetime of the drug target complex. Previously, we predicted the structure of the rate-limiting transition state that controlled the time-dependent inhibition of the enoyl-ACP reductase InhA. This led to the discovery of a triazole-containing diphenyl ether with an increased residence time on InhA due to transition-state destabilization rather than ground-state stabilization. In the present work, we evaluate the inhibition of InhA by 14 triazole-based diphenyl ethers and use a combination of enzyme kinetics and X-ray crystallography to generate a structure kinetic relationship for time-dependent binding. We show that the triazole motif slows the rate of formation for the final drug target complex by up to 3 orders of magnitude. In addition, we identify a novel inhibitor with a residence time on InhA of 220 min, which is 3.5-fold longer than that of the INH-NAD adduct formed by the tuberculosis drug, isoniazid. This study provides a clear example in which the lifetime of the drug target complex is controlled by interactions in the transition state for inhibitor binding rather than the ground state of the enzyme inhibitor complex, and demonstrates the important role that on-rates can play in drug target residence time.
引用
收藏
页码:3417 / 3429
页数:13
相关论文
共 42 条
[1]   Click Chemistry: 1,2,3-Triazoles as Pharmacophores [J].
Agalave, Sandip G. ;
Maujan, Suleman R. ;
Pore, Vandana S. .
CHEMISTRY-AN ASIAN JOURNAL, 2011, 6 (10) :2696-2718
[2]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[3]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[4]   Opinion - Drug-target residence time and its implications for lead optimization [J].
Copeland, Robert A. ;
Pompliano, David L. ;
Meek, Thomas D. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :730-739
[5]  
Copeland Robert A, 2005, Methods Biochem Anal, V46, P1
[6]   The drug-target residence time model: a 10-year retrospective [J].
Copeland, Robert A. .
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (02) :87-95
[7]   Design strategies to address kinetics of drug binding and residence time [J].
Cusack, Kevin P. ;
Wang, Ying ;
Hoemann, Michael Z. ;
Marjanovic, Jasmina ;
Heym, Roland G. ;
Vasudevan, Anil .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (10) :2019-2027
[8]   CRYSTAL-STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM-TUBERCULOSIS [J].
DESSEN, A ;
QUEMARD, A ;
BLANCHARD, JS ;
JACOBS, WR ;
SACCHETTINI, JC .
SCIENCE, 1995, 267 (5204) :1638-1641
[9]   Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA [J].
Encinas, Lourdes ;
O'Keefe, Heather ;
Neu, Margarete ;
Remuinan, Modesto J. ;
Patel, Amish M. ;
Guardia, Ana ;
Davie, Christopher P. ;
Perez-Macias, Natalia ;
Yang, Hongfang ;
Convery, Maire A. ;
Messer, Jeff A. ;
Perez-Herran, Esther ;
Centrella, Paolo A. ;
Alvarez-Gomez, Daniel ;
Clark, Matthew A. ;
Huss, Sophie ;
O'Donovan, Gary K. ;
Ortega-Muro, Fatima ;
McDowell, William ;
Castaneda, Pablo ;
Arico-Muendel, Christopher C. ;
Pajk, Stane ;
Rullas, Joaquin ;
Angulo-Barturen, Inigo ;
Alvarez-Ruiz, Emilio ;
Mendoza-Losana, Alfonso ;
Pages, Lluis Ballell ;
Castro-Pichel, Julia ;
Evindar, Ghotas .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) :1276-1288
[10]   Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis [J].
Freundlich, Joel S. ;
Wang, Feng ;
Vilcheze, Catherine ;
Gulten, Gulcin ;
Langley, Robert ;
Schiehser, Guy A. ;
Jacobus, David R. ;
Jacobs, William R., Jr. ;
Sacchettini, James C. .
CHEMMEDCHEM, 2009, 4 (02) :241-248